Skip to main content

Table 1 Clinical and laboratory characteristics of the 16 subjects

From: The effect of sodium nitrite infusion on renal function, brachial and central blood pressure during enzyme inhibition by allopurinol, enalapril or acetazolamide in healthy subjects: a randomized, double-blinded, placebo-controlled, crossover study

Gender (male/female)

5/11

Age (years)

23 [19;27]

BMI (kg/m2)

23 [20;29]

Systolic blood pressure (mmHg)

121 [111;132]

Diastolic blood pressure (mmHg)

73 [64;87]

P-alanine aminotransferase (U/l)

23 (16;28)

P-bilirubin (μmol/l)

8.0 (6.3;10.0)

P-alkaline phosphatase (U/l)

57 (44;82)

P-cholesterol (mmol/l)

4.2 [3.7;4.8]

B-glycated hemoglobin (mmol/mol)

34 (32;35)

P-thyroid stimulating hormone (mIE/l)

1.17 (0.78;2.05)

P-urate (mmol/l)

26 [22;30]

P-total CO2 in venous blood (mmol/l)

27 [26;28]

P-sodium (mmol/l)

140 [139;141]

P-potassium (mmol/l)

3.8 [3.7;3.9]

eGFRMDRD (ml/min/1.73m2)

100 [92;107]

P-albumin (g/l)

42 [40;43]

B-platelets (×109/l)

233 [208;259]

B-leukocytes (×109/l)

6.3 [5.3;7.3]

B-hemoglobin (mmol/l)

8.6 [8.2;9.0]

Hematocrit

.40 [.42;.44]

  1. Normal distributed data are presented as means with 95% confidence interval in brackets and non-parametric data as medians with 25th and 75th percentiles in parentheses. Estimated glomerular filtration rate (eGFRMDRD) is calculated using the Modification of Diet in Renal Disease Study equation